Hypertrophic Cardiomyopathy Medical Society

06/01/2026

In the Thick of It podcast episode 36: Long-Term Realities: Managing Disease Progression and ICD Selection in Young Patients. Sponsored by Cytokinetics

Patient advocates Hannah and Bethany Keime from HeartCharged sit down with Dr. John Fritzlen to discuss the long-term journey of living with hypertrophic cardiomyopathy (HCM).

The conversation covers the progressive nature of the condition and tailored approaches for counseling young or newly diagnosed patients:

❤️ Onset of heart failure symptoms
❤️ Atrial fibrillation
❤️ Myocardial remodeling
❤️ Benefits of CPET
❤️ Importance of active lifestyle management
❤️ Proactive treatment strategies
❤️ Implantable cardioverter-defibrillators
❤️ Subcutaneous & extravascular systems for younger populations

Watch the session on YouTube: https://bit.ly/4u42HBP

Learn more: https://hcmsociety.org/

05/05/2026

Reevaluating Beta Blockers: New Evidence in Non-Obstructive HCM Care is the latest episode in Season 4 of “In the Thick of It,” an HCMS podcast sponsored by Cytokinetics.

Visit the link in the comments to watch the episode.

Dr. Florian Rader joins Dr. Louise Bjerregaard to discuss a groundbreaking randomized, double-blind, triple-crossover trial that challenges the long-standing "mantra" of using beta blockers as first-line therapy for non-obstructive hypertrophic cardiomyopathy (HCM).

This episode is essential listening for clinicians looking to move beyond expert opinion toward evidence-based, personalized care for their non-obstructive HCM patients.

04/27/2026

The ODYSSEY Continues: Deep Diving into Non-Obstructive
HCM Data - Sponsored by Cytokinetics

Dr. James MacNamara welcomes Dr. Milind Desai from the Cleveland Clinic to dissect the results and implications of the ODYSSEY trial, the largest randomized trial ever conducted in hypertrophic cardiomyopathy (HCM).

The trial investigated the use of mavacamten in patients with non-obstructive HCM, a population with significant unmet medical needs.

Follow the link in the comments to listen. 👇

04/27/2026

HCMS Podcast Episode 34: The Personalized Heart: Moving beyond the 15mm Rule in HCM Diagnosis – Sponsored by Cytokinetics

Dr. John Fritzlen sits down with Dr. Hunain Shiwani to discuss a paradigm shift in diagnosing hypertrophic cardiomyopathy (HCM).

For 50 years, the medical community has relied on a static 15mm wall thickness threshold that fails to account for individual body size, age, and biological s*x; a bias that often leaves female patients underdiagnosed.

How do demographic-based thresholds reduce diagnostic bias, and empower clinicians through tools like the HCM Calculator to provide more equitable care for patients on the margins of traditional criteria?

Follow the link in the comments to learn the answer.⬇️

04/24/2026

HCM Medical Society mourns the passing of Eugene Braunwald, MD (1929-2026)

Eugene Braunwald, MD, one of the most influential figures in cardiovascular medicine, has died. He was 96.

The initiator of HCMS' endowed Eugene Braunwald Lectureship Award https://bit.ly/3R0rhFB and longtime director of the HCM Medical Society https://hcmsociety.org/ , Dr. Braunwald authored the seminal studies at the National Institutes of Health in the 1960s that defined the diagnosis of hypertrophic cardiomyopathy (HCM) as a clinical entity and served as the foundation for advancements in echocardiographic diagnosis, genetic testing, and risk stratification for sudden cardiac death.

Learn more about Dr. Braunwald in the comments below ⬇️

Donations in support of Dr. Braunwald's memory can be made to his lectureship award: https://bit.ly/3Qw74aD

With a career in medicine spanning eight decades, Braunwald will be remembered for his impact on every corner of the field.

04/15/2026

1–3 Hours/Month. Real Impact.

Your expertise can make a measurable difference in HCM care—without adding a major time burden.

The Hypertrophic Cardiomyopathy Medical Society https://hcmsociety.org/ is seeking physicians and care providers for flexible, high-impact volunteer roles (as little as 1–3 hours/month), including:

❤️Clinical education & guidelines
❤️Mentorship
❤️Research & thought leadership
❤️Focused communities working to improve patient outcomes.

Get involved at HCMS Call for Volunteers https://bit.ly/3Qe2TQD

Your expertise can make a measurable difference in HCM care—without adding a major time burden. The Hypertrophic Cardiomyopathy Medical Society is seeking physicians for flexible, high-impact volunteer roles (as little as 1–3 hours/month). Let us know how you want to help! For additional in...

02/27/2026

This week we recognized HCM Awareness Day on Feb. 25 by highlighting early detection of Hypertrophic Cardiomyopathy, an underdiagnosed genetic heart condition affecting 1 in 500 people of all ages. Early detection leads to effective treatment that can save lives.

The Hypertrophic Cardiomyopathy Medical Society brings together a community of physicians, scientists and medical providers dedicated to improving the diagnosis and treatment of people with HCM through clinical excellence, research and education.

Visit www.hcms.org to view our podcast series, register for our annual scientific sessions, review videos from past events, and join like-minded professionals dedicated to sharing knowledge and working toward improving patient outcomes.

02/26/2026

This week we are recognizing HCM Awareness Day, observed on Feb. 25. We’re highlighting early detection of Hypertrophic Cardiomyopathy, an underdiagnosed genetic heart condition affecting 1 in 500 people of all ages. Early detection leads to effective treatment that can save lives.

The Hypertrophic Cardiomyopathy Medical Society brings together a community of physicians, scientists and medical providers dedicated to improving the diagnosis and treatment of people with HCM through clinical excellence, research and education.

For just $99 you can join HCMS as a member and enjoy benefits that will enhance your professional growth and connect you with like-minded professionals dedicated to sharing knowledge and working toward improving patient outcomes. Student membership is $49.

https://hcmsociety.org/Membership

02/25/2026

February 25 is HCM Awareness Day and we’re highlighting early detection of Hypertrophic Cardiomyopathy, an underdiagnosed genetic heart condition affecting 1 in 500 people of all ages.

On this special day, we salute the groundbreaking work of Dr. Eugene Braunwald, whose seminal studies at the NIH in the 1960s defined the diagnosis of HCM as a clinical entity and served as the foundation for advancements in echocardiographic diagnosis, genetic testing, and risk stratification for sudden cardiac death.

Learn more about Dr. Braunwald and contribute to the Eugene Braunwald, MD Endowed Lecture. This speakership enables HCMS to host pioneering researchers and pre-eminent thought leaders at our annual scientific sessions.

https://bit.ly/3MrdaHO

02/24/2026

February 25 is HCM Awareness Day and we’re highlighting early detection of Hypertrophic Cardiomyopathy.

Some people with hypertrophic cardiomyopathy don’t have symptoms, while others may only feel symptoms with exercise or exertion. And, some people may not show signs in the early stages of the disease but may develop them over time.

The Hypertrophic Cardiomyopathy Medical Society (HCMS) brings together a community of physicians, scientists and medical providers dedicated to improving the diagnosis and treatment of people with HCM through clinical excellence, research and education.

Visit us at https://hcmsociety.org/ to learn more about our podcasts, annual scientific session and to join a professional association of like-minded professionals who share their knowledge and passion for improving outcomes for patients with HCM.